<HTML>
<HEAD>
<TITLE>BCA Spring Meeting 2002: Scientific Program
</TITLE>
</HEAD>
<BODY BGCOLOR=#FFFFFF
      TEXT=#000000
      ALINK=#FF0000
      LINK=#0000FF
      VLINK=#AA00FF>
<P>
<CENTER>
<TABLE WIDTH=100%>
<TR>
<TD ALIGN=LEFT><A HREF="../../index.html"><IMG SRC="../../images/bcalogo3.gif" 
WIDTH=80 HEIGHT=90 BORDER=0></A></TD>
<TD ALIGN=CENTER><FONT SIZE=+2><B><A HREF="bca02.htm#times">BCA Spring Meeting
2002</A></B></FONT>
<P><B>University of Nottingham</B>
<P><B><FONT SIZE=+1>Monday 25 March to Thursday 28 March 2002</FONT></B>
</TD>
<TD ALIGN=RIGHT><A HREF="http://www.nottingham.ac.uk"><IMG SRC="nottlogo.gif" WIDTH=69 HEIGHT=89 BORDER=0></A></TD>
</TR>
</TABLE>
</CENTER>
<P>
<HR SIZE=2 NOSHADE>
<P>
<CENTER>
<FONT SIZE=+1><B><I><A HREF="program.htm">Scientific Program</A></I></B></FONT>
<P>
<FONT SIZE=+1 COLOR=#FF0000><B>Protein Crystallography of Drugs and Disease</B></FONT>
<P>
Wednesday 27 March, 09:00 - 10:30 & 11:00 - 12:30
<P>
Organiser: Jonas Emsley
</CENTER>
<P>
Speakers from both academic and commercial backgrounds will present their 
data on protein structures of biomedical interest and strategies for 
drug design. The speakers will include: 
<UL>
<LI><B>William Hunter</B> (Dundee University) - 
<I>The Pteridine Reductase of Trypanosomatid Parasites and Anti-folate 
Drug Resistance</I>; 
</LI>
<P>
<LI><B>Andrew Pannifer</B> (Astrazeneca) -
<I>Structure of the anthrax lethal factor</I>; 
</LI>
<P>
<LI><B>Harren Jhoti</B> (Astex) -
<I>Structure Based Lead Discovery</I>; and 
</LI>
<P>
<LI><B>Richard Pauptit</B> (Astrazeneca) -
<I>Drug Design Trends and Strategies</I>.
</LI>
</UL>
<P>
<HR SIZE=2 NOSHADE>
</BODY>
</HTML>
